Course Provider
Learning Objectives
Enhance my diagnostic approach by incorporating a comprehensive assessment of ISM symptoms including, where indicated, the use of blood tests, bone marrow biopsies and genetic testing for KIT mutations to ensure timely and accurate diagnosis of ISM.
Utilize molecular testing, including KIT mutation analysis, as a standard part of the diagnostic process for individuals suspected of having ISM, and stay updated on emerging biomarker data to improve diagnostic accuracy.
Integrate new US Food and Drug Administration (FDA)-approved treatments for ISM into my practice, carefully evaluating the suitability of these therapies and traditional treatments, to provide the most effective symptom management for individuals with ISM.
Facilitate interdisciplinary collaboration by engaging with hematologists, allergists, dermatologists and other specialists to develop comprehensive and individualized treatment plans for individuals with ISM, with the goal of improving health care and outcomes.